Eye Health Academy - Eye Health Academy

Eye Health Academy Hero

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Popular

Why Staging TED Correctly Matters Even When CAS Is Low
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®
Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
Applying CAS, EUGOGO, VISA: A Micro Case
Applying CAS, EUGOGO, VISA: A Micro Case
MinuteCE®
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
Designing Efficient Clinic Workflows for TED Therapy Access
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®
Designing Efficient Clinic Workflows for TED Therapy Access
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
In-Person Event
Genesis & Tell-All-Tribune: Where the Future of Aesthetics and Regenerative Medicine Begins
August 21, 2026
Miami, Florida
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Eye on Ocular Health
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Steven Yeh, MD, FASRS
- Steven Yeh, MD, FASRS
Where Drops for Presbyopia Fit in My Practice
Where Drops for Presbyopia Fit in My Practice
Modern Optometry
Where Drops for Presbyopia Fit in My Practice
Mark Dunbar
- Mark Dunbar

Clinical Practice

MinuteCE®
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 credit 8 episodes
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 credit 8 episodes
Why QoL Measures Change TED Management
Why QoL Measures Change TED Management
MinuteCE®
Why QoL Measures Change TED Management
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Recognizing Geographic Atrophy Progression in AMD
Recognizing Geographic Atrophy Progression in AMD
Eye on Ocular Health
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP; Jaclyn Kovach, MD
- Brian P. McDonough, MD, FAAFP
- Jaclyn Kovach, MD
Observation vs. Vitrectomy for Floaters
Observation vs. Vitrectomy for Floaters
Ophthalmology
Observation vs. Vitrectomy for Floaters
Kyle Davis Kovacs, MD; Matthew Starr, MD
- Kyle Davis Kovacs, MD
- Matthew Starr, MD
- Nita Valikodath, MD, MS
New Methotrexate Protocol in RD Repair in High-Risk PVR Cases
New Methotrexate Protocol in RD Repair in High-Risk PVR Cases
General Ophthalmology
New Methotrexate Protocol in RD Repair in High-Risk PVR Cases
Maria H. Berrocal, MD; Maggie Runner, MD
- Maria H. Berrocal, MD
- Maggie Runner, MD
Choosing the Right Therapy for RVO Patients
Choosing the Right Therapy for RVO Patients
Eye on Ocular Health
Choosing the Right Therapy for RVO Patients
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Eye on Ocular Health
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast Replay
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD; Andrew G. Lee, MD
1.00 credit
- Prem S. Subramanian, MD, PhD
- Andrew G. Lee, MD
- Valerie Biousse, MD
1.00 credit